We are live on ! Find out more
ARVN icon

Arvinas

215 hedge funds and large institutions have $458M invested in Arvinas in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 72 increasing their positions, 61 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more call options, than puts

Call options by funds: $23.4M | Put options by funds: $10.5M

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

18% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 61

9% more funds holding

Funds holding: 198215 (+17)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

16.79% less ownership

Funds ownership: 111.45%94.65% (-17%)

69% less capital invested

Capital invested by funds: $1.47B → $458M (-$1.01B)

Holders
215
Holders Change
+17
Holders Change %
+8.59%
% of All Funds
2.88%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.08%
New
54
Increased
72
Reduced
61
Closed
36
Calls
$23.4M
Puts
$10.5M
Net Calls
+$12.9M
Net Calls Change
-$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
226
Panagora Asset Management
Massachusetts
-$5.7M -297,186 Closed
FLSM
227
Frazier Life Sciences Management
California
-$5.47M -285,331 Closed
BC
228
BIT Capital
Germany
-$5.05M -263,527 Closed
American Century Companies
229
American Century Companies
Missouri
-$4.84M -252,685 Closed
Neuberger Berman Group
230
Neuberger Berman Group
New York
-$3.15M -164,392 Closed
TC
231
TwinBeech Capital
New York
-$3.15M -164,112 Closed
Ameriprise
232
Ameriprise
Minnesota
-$2.23M -116,513 Closed
PHP
233
Parkman Healthcare Partners
Connecticut
-$2.05M -106,871 Closed
PSC
234
Patient Square Capital
California
-$1.66M -86,627 Closed
Aberdeen Group
235
Aberdeen Group
United Kingdom
-$1.51M -78,585 Closed
Bank of Montreal
236
Bank of Montreal
Ontario, Canada
-$755K -39,407 Closed
Voloridge Investment Management
237
Voloridge Investment Management
Florida
-$749K -39,063 Closed
SG Americas Securities
238
SG Americas Securities
New York
-$622K -32,424 Closed
M&T Bank
239
M&T Bank
New York
-$608K -31,673 Closed
BHCM
240
Brevan Howard Capital Management
Jersey
-$369K -19,249 Closed
DnB Asset Management
241
DnB Asset Management
Norway
-$196K -10,234 Closed
Skandinaviska Enskilda Banken (SEB)
242
Skandinaviska Enskilda Banken (SEB)
Sweden
-$187K -9,806 Closed
VEA
243
Virtus ETF Advisers
New York
-$69K -3,601 Closed
CAS
244
Coppell Advisory Solutions
Texas
-$21.1K -1,133 Closed
BIG
245
Brooklyn Investment Group
New York
-$15.3K -797 Closed
VWM
246
Venturi Wealth Management
Texas
-$4.64K -242 Closed
AWM
247
Avior Wealth Management
Nebraska
-$4.45K -232 Closed
ACM
248
Aster Capital Management
United Arab Emirates
-$1.09K -57 Closed
AAP
249
Arax Advisory Partners
Colorado
-$652 -34 Closed
CPG
250
Cornerstone Planning Group
New Jersey
-$310 -17 Closed

ARVN Hedge Fund Activity: Q1 2025 in Review

215 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Arvinas (ARVN) for Q1 2025, worth a combined $458M — down 69% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new ARVN positions and 36 closed out — a net gain of 18 holders — while 72 added to existing stakes and 61 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $28.2M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $129M sold.

  • 215 institutional investors held Arvinas (ARVN) as of Q1 2025, up from 198 in Q4 2024.
  • Funds reported $458M of Arvinas stock for Q1 2025, down 69% quarter-over-quarter.
  • 54 funds opened new Arvinas positions in Q1 2025 and 36 closed out, a net change of +18 holders.
  • The largest Arvinas buyer in Q1 2025 was Alyeska Investment Group, an estimated $28.2M added.
  • The largest Arvinas seller in Q1 2025 was EcoR1 Capital, an estimated $129M sold.

Based on aggregated 13F filings for Q1 2025.